PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cell Biology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.\', \'Program in Cellular and Molecular Medicine, Boston Children\'s Hospital, Boston, Massachusetts, USA.\', \'Department of Virology, Faculty of Medicine, University of Helsinkigrid.7737.4, Helsinki, Finland.\', \'Program in Virology, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.\', \'Department of Veterinary Biosciences, University of Helsinkigrid.7737.4, Helsinki, Finland.\', \'Virology and Immunology, Helsinki University Hospital Diagnostic Center (HUSLAB), Helsinki, Finland.\', \'Department of Pediatrics, Harvard Medical Schoolgrid.471403.5, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JVI.00975-21
?:hasPublicationType
?:journal
  • Journal of virology
is ?:pmid of
?:pmid
?:pmid
  • 34406858
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.853
?:rankingScore_hIndex
  • 268
is ?:relation_isRelatedTo_publication of
?:title
  • Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34406858>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34406858>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all